Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
Clinical trial NCT03839498 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03839498
- Sponsor
- Columbia University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2027-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.